|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
674,040,000 |
Market
Cap: |
16.71(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$17.15 - $26.07 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
27,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
27,872 |
27,872 |
60,449 |
163,424 |
Total Sell Value |
$687,456 |
$687,456 |
$1,380,595 |
$4,309,849 |
Total People Sold |
3 |
3 |
4 |
5 |
Total Sell Transactions |
4 |
4 |
6 |
15 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Couturier Christophe |
EVP, AMEA |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
26,818 |
125,849 |
|
- |
|
Szlosek Thomas A |
EVP & CFO |
|
2023-01-31 |
4 |
D |
$23.90 |
$578,069 |
D/D |
(24,187) |
124,574 |
|
- |
|
Szlosek Thomas A |
EVP & CFO |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
53,636 |
148,761 |
|
- |
|
Miller Justin |
EVP & General Counsel |
|
2023-01-31 |
4 |
D |
$23.90 |
$189,814 |
D/D |
(7,942) |
98,842 |
|
- |
|
Miller Justin |
EVP & General Counsel |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
26,818 |
106,784 |
|
- |
|
Stubblefield Michael |
CEO |
|
2023-01-31 |
4 |
D |
$23.90 |
$2,178,246 |
D/D |
(91,140) |
1,210,266 |
|
- |
|
Stubblefield Michael |
CEO |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
223,482 |
1,301,406 |
|
- |
|
Vanderhaegen Frederic |
EVP, Americas & Europe |
|
2023-01-31 |
4 |
D |
$23.90 |
$60,109 |
D/D |
(2,515) |
168,547 |
|
- |
|
Vanderhaegen Frederic |
EVP, Americas & Europe |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
44,669 |
171,062 |
|
- |
|
Brophy Gerard |
EVP, Biopharma Production |
|
2023-01-02 |
4 |
D |
$21.09 |
$141,872 |
D/D |
(6,727) |
90,208 |
|
- |
|
Vanderhaegen Frederic |
EVP, Americas & Europe |
|
2023-01-02 |
4 |
D |
$21.09 |
$21,449 |
D/D |
(1,017) |
126,363 |
|
- |
|
Szlosek Thomas A |
EVP & CFO |
|
2023-01-02 |
4 |
D |
$21.09 |
$175,321 |
D/D |
(8,313) |
109,395 |
|
- |
|
Lewis Sheri |
EVP, Global Ops & Supply Chain |
|
2022-12-31 |
4 |
D |
$21.09 |
$128,122 |
D/D |
(6,075) |
65,373 |
|
- |
|
Henson Meghan |
EVP, Chief HR Officer |
|
2022-12-31 |
4 |
D |
$21.09 |
$37,751 |
D/D |
(1,790) |
29,615 |
|
- |
|
Stubblefield Michael |
CEO |
|
2022-11-16 |
4 |
B |
$20.95 |
$314,250 |
I/I |
15,000 |
429,500 |
2.66 |
4% |
|
Szlosek Thomas A |
EVP & CFO |
|
2022-11-16 |
4 |
B |
$20.71 |
$258,850 |
I/I |
12,500 |
35,668 |
1.99 |
4% |
|
Vanderhaegen Frederic |
EVP, Americas & Europe |
|
2022-05-23 |
4 |
S |
$31.61 |
$1,232,790 |
D/D |
(39,000) |
126,764 |
|
36% |
|
Brophy Gerard |
EVP, Biopharma Production |
|
2022-05-20 |
4 |
AS |
$31.27 |
$612,986 |
D/D |
(19,603) |
96,935 |
|
-37% |
|
Brophy Gerard |
EVP, Biopharma Production |
|
2022-05-17 |
4 |
D |
$31.33 |
$616,668 |
D/D |
(19,683) |
116,538 |
|
- |
|
Miller Justin |
EVP & General Counsel |
|
2022-05-17 |
4 |
D |
$31.33 |
$405,254 |
D/D |
(12,935) |
79,312 |
|
- |
|
Vanderhaegen Frederic |
EVP, Americas & Europe |
|
2022-05-17 |
4 |
D |
$31.33 |
$69,239 |
D/D |
(2,210) |
165,764 |
|
- |
|
Couturier Christophe |
EVP, AMEA |
|
2022-05-17 |
4 |
D |
$31.33 |
$507,922 |
D/D |
(16,212) |
98,348 |
|
- |
|
Eck Steven W |
SVP & Chief Accounting Officer |
|
2022-05-17 |
4 |
D |
$31.33 |
$17,952 |
D/D |
(573) |
17,747 |
|
- |
|
Szlosek Thomas A |
EVP & CFO |
|
2022-05-17 |
4 |
D |
$31.33 |
$728,767 |
D/D |
(23,261) |
140,260 |
|
- |
|
Stubblefield Michael |
President and CEO |
|
2022-05-17 |
4 |
D |
$31.33 |
$3,405,571 |
D/D |
(108,700) |
1,189,841 |
|
- |
|
534 Records found
|
|
Page 6 of 22 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|